0001104659-22-065250.txt : 20220526
0001104659-22-065250.hdr.sgml : 20220526
20220526160535
ACCESSION NUMBER: 0001104659-22-065250
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220525
FILED AS OF DATE: 20220526
DATE AS OF CHANGE: 20220526
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FLESHNER NEIL E.
CENTRAL INDEX KEY: 0001868209
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39373
FILM NUMBER: 22969931
MAIL ADDRESS:
STREET 1: 4850 WEST 78TH STREET
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46268
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: POINT Biopharma Global Inc.
CENTRAL INDEX KEY: 0001811764
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 850800493
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4850 WEST 78TH STREET
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46268
BUSINESS PHONE: (317) 543-9957
MAIL ADDRESS:
STREET 1: 4850 WEST 78TH STREET
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46268
FORMER COMPANY:
FORMER CONFORMED NAME: Therapeutics Acquisition Corp.
DATE OF NAME CHANGE: 20200511
4
1
tm2217064d1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-05-25
0
0001811764
POINT Biopharma Global Inc.
PNT
0001868209
FLESHNER NEIL E.
4850 WEST 78TH STREET
INDIANAPOLIS
IN
46268
1
1
0
0
Chief Medical Officer
Common Stock
2022-05-25
4
S
0
564204
7.51
D
3023045
D
Common Stock
233171
I
1510789 Ontario Inc.
Common Stock
358
I
Trust Controlled by Wife
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.75, inclusive. The reporting person undertakes to provide to POINT Biopharma Global Inc., any security holder of POINT Biopharma Global Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
A corporation controlled by Reporting Person.
A trust, whose trustee is the Reporting Person's spouse.
/s/ William L. Demers, by Power of Attorney for Neil E. Fleshner
2022-05-26